Latest Breaking News On - Swiss biopharmaceutical group - Page 1 : comparemela.com

Helsinn and Xediton sign exclusive license and distribution agreement for TRUSELTIQ™ (infigratinib) in Canada

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

United statesGeorge gafreyPaola bonviciniRiccardo bragliaHelsinn group viceOncology centerInternational healthcareXediton pharmaceuticalsDrug administrationXediton pharmaceuticals incHelsinn groupHealth canada notice of complianceGroup head of communicationSwiss biopharmaceutical groupHelsinn group media contactHealth canada

Helsinn and Xediton sign exclusive license and distribution agreement for TRUSELTIQ™ (infigratinib) in Canada | Comunicados | Edición USA

Helsinn and Xediton sign exclusive license and distribution agreement for TRUSELTIQ™ (infigratinib) in Canada | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

United statesGeorge gafreyPaola bonviciniRiccardo bragliaHelsinn group viceOncology centerInternational healthcareXediton pharmaceuticalsDrug administrationXediton pharmaceuticals incHelsinn groupHealth canada notice of complianceGroup head of communicationSwiss biopharmaceutical groupHelsinn group media contactHealth canada

Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR | Comunicados | Edición USA

Helsinn and Fosun Pharma sign exclusive license and distribution agreements for Aloxi®, Akynzeo® oral, NEPA IV and anamorelin in Mainland China, Hong Kong SAR and Macau SAR | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

Hong kongBarney liuPaola bonviciniFosun pharmasignRiccardo bragliaWu yifangFosun pharmaIreland helsinn birex pharmaceuticals ltdHelsinn group viceSinopharm co ltdUs helsinn therapeutics incShanghai fosun pharmaceutical group co ltdShanghai fosun pharmaceutical industrial development coHelsinn groupChina helsinn pharmaceuticals beijing co ltdChina national medical products administration

Helsinn Healthcare S A : Helsinn Group announces oral presentation of data at AACR-NCI-EORTC relating to a potent and highly selective investigational RET inhibitor

Helsinn Group announces oral presentation of data at AACR-NCI-EORTC relating to a potent and highly selective investigational RET inhibitor Lugano, Switzerland, 7 October 2021 - Helsinn

Isao miyazakiKostenloser wertpapierhandelPaola bonviciniJohns hopkinsSergio cantoreggiIreland helsinn birex pharmaceuticals ltdUs helsinn therapeutics incTaiho pharmaceutical co ltdVirtual international conference on molecularChina helsinn pharmaceuticals beijing co ltdGroup head of communicationSwiss biopharmaceutical groupHelsinn group media contactGroup headHelsinn groupOtsuka holdings co ltd

Helsinn Group announces oral presentation of data at AACR-NCI-EORTC relating to a potent and highly selective investigational RET inhibitor | Comunicados | Edición USA

Helsinn Group announces oral presentation of data at AACR-NCI-EORTC relating to a potent and highly selective investigational RET inhibitor | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

Isao miyazakiPaola bonviciniJohns hopkinsSergio cantoreggiIreland helsinn birex pharmaceuticals ltdUs helsinn therapeutics incTaiho pharmaceutical co ltdVirtual international conference on molecularChina helsinn pharmaceuticals beijing co ltdGroup head of communicationSwiss biopharmaceutical groupHelsinn group media contactGroup headHelsinn groupOtsuka holdings co ltdInternational conference